Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition-A Prospective Multicenter Study.
Blesl A, Wurm P, Waschina S, Gröchenig HP, Novacek G, Primas C, Reinisch W, Kutschera M, Illiasch C, Hennlich B, Steiner P, Koch R, Tillinger W, Haas T, Reicht G, Mayer A, Ludwiczek O, Miehsler W, Steidl K, Binder L, Reider S, Watschinger C, Fürst S, Kump P, Moschen A, Aden K, Gorkiewicz G, Högenauer C. Blesl A, et al. Among authors: kutschera m. Inflamm Bowel Dis. 2024 Jan 5;30(1):9-19. doi: 10.1093/ibd/izad126. Inflamm Bowel Dis. 2024. PMID: 37463118 Free PMC article.
Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Gröchenig HP, Waldhör T, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Kutschera M, Dejaco C, Vogelsang H, Novacek G; Austrian IBD Study Group (ATISG). Gröchenig HP, et al. Among authors: kutschera m. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1211-1219. doi: 10.1097/MEG.0000000000001533. Eur J Gastroenterol Hepatol. 2019. PMID: 31498280
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.
Kutschera M, Waldhör T, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Peters PG, Reicht G, Moser G, Dejaco C, Vogelsang H, Primas C, Novacek G, Miehsler W; Austrian IBD Study Group. Kutschera M, et al. United European Gastroenterol J. 2021 Feb;9(1):72-81. doi: 10.1177/2050640620946874. Epub 2021 Feb 18. United European Gastroenterol J. 2021. PMID: 32723070 Free PMC article.
Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
Scharrer S, Primas C, Eichinger S, Tonko S, Kutschera M, Koch R, Blesl A, Reinisch W, Mayer A, Haas T, Feichtenschlager T, Fuchssteiner H, Steiner P, Ludwiczek O, Platzer R, Miehsler W, Tillinger W, Apostol S, Schmid A, Schweiger K, Vogelsang H, Dejaco C, Herkner H, Novacek G; Austrian IBD Study Group. Scharrer S, et al. Among authors: kutschera m. Inflamm Bowel Dis. 2021 Oct 20;27(11):1773-1783. doi: 10.1093/ibd/izaa337. Inflamm Bowel Dis. 2021. PMID: 33386735
Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH).
Kutschera M, Novacek G, Reinisch W, Högenauer C, Petritsch W, Haas T, Moschen A, Dejaco C. Kutschera M, et al. Wien Klin Wochenschr. 2023 Jan;135(1-2):1-13. doi: 10.1007/s00508-022-02110-2. Epub 2022 Dec 1. Wien Klin Wochenschr. 2023. PMID: 36454302 Free PMC article.
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial.
Blesl A, Borenich A, Gröchenig HP, Novacek G, Primas C, Reinisch W, Kutschera M, Illiasch C, Hennlich B, Steiner P, Koch R, Tillinger W, Haas T, Reicht G, Mayer A, Ludwiczek O, Miehsler W, Steidl K, Binder L, Baumann-Durchschein F, Fürst S, Reider S, Watschinger C, Wenzl H, Moschen A, Berghold A, Högenauer C; Austrian IBD Study Group (ATISG). Blesl A, et al. Among authors: kutschera m. J Clin Med. 2023 Jul 24;12(14):4853. doi: 10.3390/jcm12144853. J Clin Med. 2023. PMID: 37510968 Free PMC article.
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.
Wagner A, Garner-Spitzer E, Schötta AM, Orola M, Wessely A, Zwazl I, Ohradanova-Repic A, Weseslindtner L, Tajti G, Gebetsberger L, Kratzer B, Tomosel E, Kutschera M, Tobudic S, Pickl WF, Kundi M, Stockinger H, Novacek G, Reinisch W, Zielinski C, Wiedermann U. Wagner A, et al. Among authors: kutschera m. Front Immunol. 2022 May 12;13:889138. doi: 10.3389/fimmu.2022.889138. eCollection 2022. Front Immunol. 2022. PMID: 35634285 Free PMC article. Clinical Trial.
Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon.
Ahmad WAW, Nuruddin AA, Abdul Kader MASK, Ong TK, Liew HB, Ali RM, Mahmood Zuhdi AS, Ismail MD, Yusof AKM, Schwenke C, Kutschera M, Scheller B. Ahmad WAW, et al. Among authors: kutschera m. JACC Cardiovasc Interv. 2022 Apr 11;15(7):770-779. doi: 10.1016/j.jcin.2022.01.012. Epub 2022 Mar 16. JACC Cardiovasc Interv. 2022. PMID: 35305906 Free article. Clinical Trial.
24 results